advertisement

21st Annual Women’s Health Annual Visit (WHAV)

Transforming Women’s Healthcare, One Visit at a Time
For over 2 decades, the Women’s Health Annual Visit (WHAV) has been the go-to platform for ob-gyns, primary care physicians (PCPs), nurse practitioners, and physician assistants to access cutting-edge education tailored specifically to women’s health.

Live Meeting
6.00 available credits
Information
September 20, 2025
08:00 AM - 04:00 PM EDT
New York Marriott Marquis
1535 Broadway, Room: Westside Salon (5th Floor), New York, New York, United States
ReachMD Healthcare Image
Details
Presenters
  • Overview

    Join our esteemed chairs, Barbara Dehn, NP, and Anita Nelson, MD, and connect with fellow healthcare professionals for a dynamic, interactive, and evidence-based learning experience that extends beyond the annual visit.

    Why Attend WHAV 2025?

    ✅ Learn From Experts – Engage with world-renowned speakers and other key opinion leaders in women’s health
    ✅ Explore Emerging Trends – Gain insights into the latest advances in treatment, technology, and clinical guidelines
    ✅ Multimodal Learning – Gain exclusive access to digital content and expert-led podcasts designed to extend your live experience 
    ✅ Networking & Collaboration – Connect with industry leaders, peers, and innovators committed to improving women’s health

  • Program Schedule*

    8:00 AM – 8:30 AM | Chair’s Introduction 

    • Check-in and badge pick-up
    • Introduction of faculty and program overview
    • Conference goals and learning objectives 

    8:30 PM – 9:30 AM | Not Just a Headache: Migraine Across Women’s Lifespan  

    • Learn how to screen for migraine, recognize hormonally influenced patterns, and guide treatment decisions based on life stage, goals, and preferences. Faculty discuss acute and preventive strategies, shared decision-making, and when to refer to specialty care. 

    9:30 AM – 10:30 AM | Networking Break & Exhibits Open 

    • Coffee and refreshments
    • Sponsor/exhibitor tables open 

    10:30 AM – 11:30 AM | ENDOVOICE Live:  Endometriosis - A Chronic Burden of Reproductive/Years  

    • Understand how delayed diagnosis, implicit bias, and care disparities impact women with endometriosis. Faculty discuss strategies to improve endometriosis diagnosis and management, including GnRH antagonist use and patient-centered care approaches. 

    11:00 AM – 12:00 PM | Diagnosing and Treating IBS: It Begins with One Simple Question 

    • Learn how to diagnose and manage IBS in women by starting with one essential question about bowel habits. Gain practical tools for timely diagnosis, evidence-based treatment (non-pharmacologic and pharmacologic), and improved patient communication. 

    12:00 PM – 1:00 PM | Lunch Innovation Theater 

    • Non-CME educational presentation
    • Lunch provided for attendees
    • Sponsor/exhibitor tables open 

    1:00 PM – 2:00 PM | Women’s Sleep Health – Addressing Gaps in OSA Diagnosis and Treatment Across Life Stages 

    • Recognize how obstructive sleep apnea presents differently in women, often leading to underdiagnosis and delayed care. This session explores gender-specific screening challenges, risks during menopause and pregnancy, and tailored treatment strategies beyond CPAP. 

    2:00 PM – 2:30 PM | Networking Break & Exhibits Open 

    • Coffee and refreshments
    • Sponsor/exhibitor tables open 

    2:30 PM – 3:30 PM | Primary Biliary Cholangitis: Shining Light on an “Invisible” Female Health Burden  

    • Recognize how primary biliary cholangitis presents in women, with distinct patterns in symptoms, comorbidities, and complications. Gain practical strategies to identify clinical clues, confirm diagnosis, initiate timely referral, and understand the role of first- and second-line therapies to improve outcomes. 

    3:30 PM – 5:00 PM | Closing Session & Reception:  Patient Perspectives in Women’s Health Roundtable 

    • A panel discussion among patient representatives and expert faculty regarding burning questions in women’s health, including menopause, fibroids and osteoporosis. 

    *Subject to change

  • Disclosure of Relevant Financial Relationships

    In accordance with the ACCME Standards for Integrity and Independence, Global Learning Collaborative (GLC) requires that individuals in a position to control the content of an educational activity disclose all relevant financial relationships with any ineligible company. GLC mitigates all conflicts of interest to ensure independence, objectivity, balance, and scientific rigor in all its educational programs.

    Chair:

    Barbara Dehn, NP
    Nurse Practitioner
    Planned Parenthood
    Albany, NY

    Barbara Dehn has reported the following relevant financial relationships or relationships with ineligible companies of any amount during the past 24 months:

    Advisor/Consultant: Acella, Avion, Bonafide, Pharmavite, Shield Therapeutics
    Vendor: Cord Blood Registry

    Anita L. Nelson, MD
    Professor and Chair of Obstetrics & Gynecology
    Western University of Health Sciences, Pomona, CA
    Professor Emeritus, Obstetrics & Gynecology, UCLA
    Los Angeles, CA

    Dr. Nelson has reported the following relevant financial relationships or relationships with ineligible companies of any amount during the past 24 months:
    Consulting Fees: Bayer, Exeltis USA, Inc, Merck, Myovant, Sumitomo Pharma America, Inc
    Contracted Research: Daré Bioscience,Mylan Pharmaceuticals, Organon & Co, Sebela Pharmaceuticals, Sumitomo Pharma America, Viatris Pharmaceuticals, Inc 

    Reviewers/Content Planners/Authors: 

    • Cindy Davidson has no relevant relationships to disclose. 
  • Learning Objectives

    Upon completion of this activity, learners should be better able to:

    • Recognize the spectrum of underdiagnosed chronic conditions in women.

    • Diagnosis and management of medical conditions that disproportionately or uniquely affect women.

    • Utilize multidisciplinary approaches to address women's complex health needs. 

    • Emerging therapies and cutting-edge technologies relevant to women's health.

  • Target Audience

    This activity has been designed to meet the educational needs of ob/gyns and ob/gyn advanced practice nurses as well as all other physicians, physician assistants, nurse practitioners, nurses, pharmacists, and healthcare professionals who manage the health needs of female patients.

  • Accreditation and Credit Designation Statements

     

    In support of improving patient care, Global Learning Collaborative (GLC) is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC) to provide continuing education for the healthcare team. 

    Global Learning Collaborative (GLC) designates this live activity for a maximum of 6.0 AMA PRA Category 1 Credit(s)™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

    Global Learning Collaborative (GLC) designates this activity for 6.0 nursing contact hour(s). Nurses should claim only the credit commensurate with the extent of their participation in the activity.

    Global Learning Collaborative (GLC) designates this activity for 6.0 contact hour(s)/0.6 CEUs of pharmacy contact hour(s).

    The Universal Activity Number for this program is JA0006235-0000-25-057-L01-P. This learning activity is knowledge-based. Your CE credits will be electronically submitted to the NABP upon successful completion of the activity. Pharmacists with questions can contact NABP customer service (custserv@nabp.net). 

    Global Learning Collaborative (GLC) has been authorized by the American Academy of PAs (AAPA) to award AAPA Category 1 CME credit(s) for activities planned in accordance with AAPA CME Criteria. This activity is designated for 6.0 AAPA Category 1 CME credit(s). PAs should claim only the credit commensurate with the extent of their participation in the activity.

  • Provider(s)/Educational Partner(s)


    Omnia Education is the leading provider of education for women’s health professionals. Our activities are recognized nationwide for providing credible, relevant, and practical information on issues impacting the female patient. Additionally, our unique focus has transformed the CME learning environment, and our ability to help learners recognize and overcome barriers to optimal performance and optimal patient outcomes has positioned us as a leader in women’s health education.

  • Disclaimer

    The views and opinions expressed in this educational activity are those of the faculty and do not necessarily represent the views of GLC and Omnia Education. This presentation is not intended to define an exclusive course of patient management; the participant should use his/her clinical judgment, knowledge, experience, and diagnostic skills in applying or adopting for professional use any of the information provided herein. Any procedures, medications, or other courses of diagnosis or treatment discussed or suggested in this activity should not be used by clinicians without evaluation of their patients’ conditions and contraindications or dangers in use, review of any applicable manufacturer’s product information, and comparison with recommendations of other authorities. Links to other sites may be provided as additional sources of information. Once you elect to access a site outside of Omnia Education you are subject to the terms and conditions of use, including copyright and licensing restriction, of that site. 

    Reproduction Prohibited
    Reproduction of this material is not permitted without written permission from the copyright owner. 

  • ADA Statement

    Event staff will be glad to assist you with any special needs (eg, physical, dietary, etc.). Please contact Andrea Mathis prior to the live event at amathis@glc.healthcare.

     

  • Sponsorships and Exhibitors

    Please reach out to Kristin Kelley at kkelley@omniaeducation.com for the WHAV 2025 Prospectus to learn more about sponsorship opportunities.

Details
Presenters
  • Overview

    Join our esteemed chairs, Barbara Dehn, NP, and Anita Nelson, MD, and connect with fellow healthcare professionals for a dynamic, interactive, and evidence-based learning experience that extends beyond the annual visit.

    Why Attend WHAV 2025?

    ✅ Learn From Experts – Engage with world-renowned speakers and other key opinion leaders in women’s health
    ✅ Explore Emerging Trends – Gain insights into the latest advances in treatment, technology, and clinical guidelines
    ✅ Multimodal Learning – Gain exclusive access to digital content and expert-led podcasts designed to extend your live experience 
    ✅ Networking & Collaboration – Connect with industry leaders, peers, and innovators committed to improving women’s health

  • Program Schedule*

    8:00 AM – 8:30 AM | Chair’s Introduction 

    • Check-in and badge pick-up
    • Introduction of faculty and program overview
    • Conference goals and learning objectives 

    8:30 PM – 9:30 AM | Not Just a Headache: Migraine Across Women’s Lifespan  

    • Learn how to screen for migraine, recognize hormonally influenced patterns, and guide treatment decisions based on life stage, goals, and preferences. Faculty discuss acute and preventive strategies, shared decision-making, and when to refer to specialty care. 

    9:30 AM – 10:30 AM | Networking Break & Exhibits Open 

    • Coffee and refreshments
    • Sponsor/exhibitor tables open 

    10:30 AM – 11:30 AM | ENDOVOICE Live:  Endometriosis - A Chronic Burden of Reproductive/Years  

    • Understand how delayed diagnosis, implicit bias, and care disparities impact women with endometriosis. Faculty discuss strategies to improve endometriosis diagnosis and management, including GnRH antagonist use and patient-centered care approaches. 

    11:00 AM – 12:00 PM | Diagnosing and Treating IBS: It Begins with One Simple Question 

    • Learn how to diagnose and manage IBS in women by starting with one essential question about bowel habits. Gain practical tools for timely diagnosis, evidence-based treatment (non-pharmacologic and pharmacologic), and improved patient communication. 

    12:00 PM – 1:00 PM | Lunch Innovation Theater 

    • Non-CME educational presentation
    • Lunch provided for attendees
    • Sponsor/exhibitor tables open 

    1:00 PM – 2:00 PM | Women’s Sleep Health – Addressing Gaps in OSA Diagnosis and Treatment Across Life Stages 

    • Recognize how obstructive sleep apnea presents differently in women, often leading to underdiagnosis and delayed care. This session explores gender-specific screening challenges, risks during menopause and pregnancy, and tailored treatment strategies beyond CPAP. 

    2:00 PM – 2:30 PM | Networking Break & Exhibits Open 

    • Coffee and refreshments
    • Sponsor/exhibitor tables open 

    2:30 PM – 3:30 PM | Primary Biliary Cholangitis: Shining Light on an “Invisible” Female Health Burden  

    • Recognize how primary biliary cholangitis presents in women, with distinct patterns in symptoms, comorbidities, and complications. Gain practical strategies to identify clinical clues, confirm diagnosis, initiate timely referral, and understand the role of first- and second-line therapies to improve outcomes. 

    3:30 PM – 5:00 PM | Closing Session & Reception:  Patient Perspectives in Women’s Health Roundtable 

    • A panel discussion among patient representatives and expert faculty regarding burning questions in women’s health, including menopause, fibroids and osteoporosis. 

    *Subject to change

  • Disclosure of Relevant Financial Relationships

    In accordance with the ACCME Standards for Integrity and Independence, Global Learning Collaborative (GLC) requires that individuals in a position to control the content of an educational activity disclose all relevant financial relationships with any ineligible company. GLC mitigates all conflicts of interest to ensure independence, objectivity, balance, and scientific rigor in all its educational programs.

    Chair:

    Barbara Dehn, NP
    Nurse Practitioner
    Planned Parenthood
    Albany, NY

    Barbara Dehn has reported the following relevant financial relationships or relationships with ineligible companies of any amount during the past 24 months:

    Advisor/Consultant: Acella, Avion, Bonafide, Pharmavite, Shield Therapeutics
    Vendor: Cord Blood Registry

    Anita L. Nelson, MD
    Professor and Chair of Obstetrics & Gynecology
    Western University of Health Sciences, Pomona, CA
    Professor Emeritus, Obstetrics & Gynecology, UCLA
    Los Angeles, CA

    Dr. Nelson has reported the following relevant financial relationships or relationships with ineligible companies of any amount during the past 24 months:
    Consulting Fees: Bayer, Exeltis USA, Inc, Merck, Myovant, Sumitomo Pharma America, Inc
    Contracted Research: Daré Bioscience,Mylan Pharmaceuticals, Organon & Co, Sebela Pharmaceuticals, Sumitomo Pharma America, Viatris Pharmaceuticals, Inc 

    Reviewers/Content Planners/Authors: 

    • Cindy Davidson has no relevant relationships to disclose. 
  • Learning Objectives

    Upon completion of this activity, learners should be better able to:

    • Recognize the spectrum of underdiagnosed chronic conditions in women.

    • Diagnosis and management of medical conditions that disproportionately or uniquely affect women.

    • Utilize multidisciplinary approaches to address women's complex health needs. 

    • Emerging therapies and cutting-edge technologies relevant to women's health.

  • Target Audience

    This activity has been designed to meet the educational needs of ob/gyns and ob/gyn advanced practice nurses as well as all other physicians, physician assistants, nurse practitioners, nurses, pharmacists, and healthcare professionals who manage the health needs of female patients.

  • Accreditation and Credit Designation Statements

     

    In support of improving patient care, Global Learning Collaborative (GLC) is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC) to provide continuing education for the healthcare team. 

    Global Learning Collaborative (GLC) designates this live activity for a maximum of 6.0 AMA PRA Category 1 Credit(s)™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

    Global Learning Collaborative (GLC) designates this activity for 6.0 nursing contact hour(s). Nurses should claim only the credit commensurate with the extent of their participation in the activity.

    Global Learning Collaborative (GLC) designates this activity for 6.0 contact hour(s)/0.6 CEUs of pharmacy contact hour(s).

    The Universal Activity Number for this program is JA0006235-0000-25-057-L01-P. This learning activity is knowledge-based. Your CE credits will be electronically submitted to the NABP upon successful completion of the activity. Pharmacists with questions can contact NABP customer service (custserv@nabp.net). 

    Global Learning Collaborative (GLC) has been authorized by the American Academy of PAs (AAPA) to award AAPA Category 1 CME credit(s) for activities planned in accordance with AAPA CME Criteria. This activity is designated for 6.0 AAPA Category 1 CME credit(s). PAs should claim only the credit commensurate with the extent of their participation in the activity.

  • Provider(s)/Educational Partner(s)


    Omnia Education is the leading provider of education for women’s health professionals. Our activities are recognized nationwide for providing credible, relevant, and practical information on issues impacting the female patient. Additionally, our unique focus has transformed the CME learning environment, and our ability to help learners recognize and overcome barriers to optimal performance and optimal patient outcomes has positioned us as a leader in women’s health education.

  • Disclaimer

    The views and opinions expressed in this educational activity are those of the faculty and do not necessarily represent the views of GLC and Omnia Education. This presentation is not intended to define an exclusive course of patient management; the participant should use his/her clinical judgment, knowledge, experience, and diagnostic skills in applying or adopting for professional use any of the information provided herein. Any procedures, medications, or other courses of diagnosis or treatment discussed or suggested in this activity should not be used by clinicians without evaluation of their patients’ conditions and contraindications or dangers in use, review of any applicable manufacturer’s product information, and comparison with recommendations of other authorities. Links to other sites may be provided as additional sources of information. Once you elect to access a site outside of Omnia Education you are subject to the terms and conditions of use, including copyright and licensing restriction, of that site. 

    Reproduction Prohibited
    Reproduction of this material is not permitted without written permission from the copyright owner. 

  • ADA Statement

    Event staff will be glad to assist you with any special needs (eg, physical, dietary, etc.). Please contact Andrea Mathis prior to the live event at amathis@glc.healthcare.

     

  • Sponsorships and Exhibitors

    Please reach out to Kristin Kelley at kkelley@omniaeducation.com for the WHAV 2025 Prospectus to learn more about sponsorship opportunities.

Register

We're glad to see you're enjoying Omnia Education…
but how about a more personalized experience?

Register for free